HomeNewsBusinessReal EstateMaharashtra govt’s decision to reduce stamp duty rates leads to increase in real estate sale registrations

Maharashtra govt’s decision to reduce stamp duty rates leads to increase in real estate sale registrations

Sale registrations in the state are at over 90 percent of pre-COVID levels, shows an analysis by Propstack.

October 01, 2020 / 17:28 IST
Story continues below Advertisement

In what could bring cheer to the real estate sector, stamp duty cut by the Maharashtra government and discounts offered by developers are encouraging homebuyers to come forward to buy property. This has led to increased sales recovery and registrations in the financial capital so much so that sales registration are at over 90 percent of pre-COVID levels, a study by Propstack, a data analytics firm has said.

According to the state government data, sale registrations stood at 207 in May after registrations reopened post the lockdown. The number increased to 1,839 in June, 2,662 in July, 2,642 in August and 5,597 in September. The September numbers were almost at par with the February sales registrations that stood at 5,927, according to an analysis by Mumbai-based Propstack, a data analytics firm.

Story continues below Advertisement

"Overall a buyer is getting an average discount of 10-15 percent on a property purchase that includes a stamp duty cut of 3 percent and over 5-10 percent discount by the developer. This is encouraging homebuyers waiting in the wings to come forward and sign on the dotted line," Sandeep Reddy, co-founder at Propstack, told Moneycontrol.

However, had it only been a stamp duty cut and no discounts from builders, the story would have been different, he said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show